Bakul Finechem Research Centre Profile
Key Indicators
- Company Age 50 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Bakul Finechem Research Centre
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Madhavi Majmudar, Yogin Majmudar, and Chinmay Majmudar serve as directors at the Company.
- CIN/LLPIN
U73100MH1974NPL017852
- Company No.
017852
- Company Classification
Public Not For Profit Company
- Incorporation Date
22 Oct 1974
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bakul Finechem Research Centre?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Madhavi Majmudar | Director | 20-May-1980 | Current |
Yogin Majmudar | Director | 30-Sep-1999 | Current |
Chinmay Majmudar | Director | 01-Sep-2009 | Current |
Financial Performance of Bakul Finechem Research Centre.
Bakul Finechem Research Centre, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Bakul Finechem Research Centre?
Unlock access to Bakul Finechem Research Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Bakul Pharma Private LimitedActive 27 years 3 months
Madhavi Majmudar and Yogin Majmudar are mutual person
- Bakul Aromatics And Chemicals Private LimitedActive 49 years 9 months
Yogin Majmudar and Chinmay Majmudar are mutual person
- Puspaj Investment Company Private LimitedActive 48 years 1 month
Madhavi Majmudar, Yogin Majmudar and 1 more are mutual person
- Gulbas Investment Private LimitedActive 33 years 11 months
Madhavi Majmudar, Yogin Majmudar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bakul Finechem Research Centre?
Unlock and access historical data on people associated with Bakul Finechem Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bakul Finechem Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bakul Finechem Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.